| Home-testing devices for diagnosing obstructive sleep apnoea hypopnoea syndrome | DG62 | | |
| Heart failure algorithms for remote monitoring in people with cardiac implantable electronic devices | DG61 | | |
| Digital technologies for assessing attention deficit hyperactivity disorder (ADHD) | DG60 | | |
| CYP2C19 genotype testing to guide clopidogrel use after ischaemic stroke or transient ischaemic attack | DG59 | | |
| Tumour profiling tests to guide adjuvant chemotherapy decisions in early breast cancer | DG58 | | |
| Artificial intelligence (AI)-derived software to help clinical decision making in stroke | DG57 | | |
| Devices for remote monitoring of Parkinson's disease | DG51 | | |
| Quantitative faecal immunochemical testing to guide colorectal cancer pathway referral in primary care | DG56 | | |
| AI-derived computer-aided detection (CAD) software for detecting and measuring lung nodules in CT scan images | DG55 | | |
| FibroScan for assessing liver fibrosis and cirrhosis outside secondary and specialist care | DG48 | | |
| Transperineal biopsy for diagnosing prostate cancer | DG54 | | |
| MRI fusion biopsy systems for diagnosing prostate cancer | DG53 | | |
| Automated ankle brachial pressure index measurement devices to detect peripheral arterial disease in people with leg ulcers | DG52 | | |
| MRI-based technologies for assessing non-alcoholic fatty liver disease | DG50 | | |
| PLGF-based testing to help diagnose suspected preterm pre-eclampsia | DG49 | | |
| Freelite assays for diagnosing multiple myeloma and related conditions (terminated assessment) | DG47 | | |
| EarlyCDT Lung for assessing risk of lung cancer in solid lung nodules | DG46 | | |
| PredictSURE IBD and IBDX to guide treatment of Crohn's disease | DG45 | | |
| SeHCAT (tauroselcholic [75 selenium] acid) for diagnosing bile acid diarrhoea | DG44 | | |
| QAngio XA 3D QFR and CAAS vFFR imaging software for assessing coronary stenosis during invasive coronary angiography | DG43 | | |
| Testing strategies for Lynch syndrome in people with endometrial cancer | DG42 | | |
| Implantable cardiac monitors to detect atrial fibrillation after cryptogenic stroke | DG41 | | |
| High-sensitivity troponin tests for the early rule out of NSTEMI | DG40 | | |
| Tests to help assess risk of acute kidney injury for people being considered for critical care admission (ARCHITECT and Alinity i Urine NGAL assays, BioPorto NGAL test and NephroCheck test) | DG39 | | |
| SepsiTest assay for rapidly identifying bloodstream bacteria and fungi | DG20 | | |